Lemieux Innovation and Research Fund at AHN Cardiovascular Institute

In September 2019, the Mario Lemieux Foundation made a $1 million gift with matching funds from Highmark Health to establish the Division of Cardiac Electrophysiology (EP) at Allegheny Health Network’s (AHN) Cardiovascular Institute. The $2 million investment will support medical research and the development of innovative therapies and technologies for heart rhythm disorders, a cause close to Mario Lemieux.

Our mission is to create programs that improve the lives of western Pennsylvanians and to collaborate with organizations who share that commitment. Allegheny Health Network’s Cardiovascular Institute is nationally recognized for its expertise in the treatment of heart and vascular disease, and we are excited to help further enhance its capabilities in the specialized care of heart rhythm disorders.
Tom Grealish
President, Mario Lemieux Foundation
Led by Amit Thosani, MD, director of the Cardiac Electrophysiology Division, AHN’s program has long been at the forefront of innovative techniques and technologies for treating heart rhythm disorders and similar heart conditions. The funding will help further establish AHN’s EP program as a center for innovative research into the cause and treatment of heart rhythm disorders with a particular focus on minimally invasive therapies for AFib.
Exceptional clinical care and pioneering expertise in the study and treatment of complex cardiovascular disease have been a hallmark of our Network and hospitals for more than a century. Patients with heart rhythm disorders can be assured that the scope of resources available to them at Allegheny Health Network is second to none.
George Magovern, MD
Chair, AHN Cardiovascular Institute